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Importance of dietary sodium in the hypercalciuria syndrome. Daily
urinary calcium excretion in renal stone-forming subjects is shown to
vary directly with moderate changes in dietary sodium intake. The
changes produced are sufficient to alter the basic diagnostic classifica-
tion from 'hypercalciuric' to 'normocalciuric' because dietary sodium is
reduced from 200 to 80 mM/day. Similar changes were observed in
fasting morning 'spot' urine samples, resulting in alteration of diagnos-
tic subclassification between so-called 'absorptive' and 'renal' catego-
ries, in the absence of demonstrable change in parathyroid function.
Diagnostic and therapeutic studies in stone-forming subjects require
control of both dietary calcium and dietary sodium if misinterpretations
are to be avoided. Habitual high sodium intake may be an etiological
factor in the generation of excessive excretion of calcium, sodium, and
phosphate — the hypercalciuria syndrome.
Importance du sodium alimentaire dans le syndrome d'hypercalciurie.
11 est montré que l'excrétion urinaire journalière de calcium chez les
sujets atteints de lithiaseurinaire vane directement avec des modifica-
tions modérées de l'apport alimentaire en sodium. Les modifications
produites sont suffisantes pour altérer Ia classification diagnostique de
base entre 'hypercalciuriques' et 'norniocalciuriques' lorsque le sodium
alimentaire est réduit de 200 a 80 mM/jour. Des modifications identiques
ont été observées sur des échantillons d'urine potictuels Ic matin àjefin,
altérant La sous-classification diagnostique entre les categories dites
'absorptives' et 'rénales' en l'absence de changement démontrable de La
fonction parathyroIdienne. Les etudes diagnostiques et thérapeutiques
chez des sujets lithiasiques demandent le contrôle ala fois do calcium et
du sodium alimentaires si Ofl veut éviter des erreurs d'interpretation.
Un apport habituel en sodium élevé pourrait être un facteur Ctiologique
dans l'apparition d'une excretion excessive de calcium, sodium et
phosphate — le syndrome d'hypercalciurie.
Renal stone disease is commonly due to hypercalciuria,
which may be assessed either from 24-hr urinary collections or
from the fasting 'spot' morning urine [1]. Results may some-
times be variable, however, and a number of collections are
usually necessary before the pattern is clear. It is generally
accepted that dietary calcium should be moderately restricted
before recording urinary calcium, but there is a lack of unanim-
ity on the question of dietary sodium adjustment during this
time. Kleeman et al [2] demonstrated marked changes in urine
calcium in normal subjects following large alterations in sodium
intake from 20 to 425 mEq/day. Lemann, Adams, and Gray [3]
recently concluded, however, that dietary sodium manipulation
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within more usual limits resulted in relatively small changes in
urinary calcium.
Many past observations in the physiological literature have
shown a close relationship between urinary calcium and sodium
excretion [4—71. However, recent clinical studies have laid little
emphasis on the possible effect of changes in urinary sodium on
tubular reabsorption of calcium [3, 8]. Prelimjnary data in three
subjects studied by us suggested that important changes in
urinary calcium resulted from a short-term reduction in dietary
sodium from 200 to 60 mEq daily [1]. Since such a change might
occur easily with normal day-to-day dietary sodium variation, it
seemed desirable to study the question further in a larger group
and over a longer period of time. If an important effect of
dietary sodium variation could be shown, and if it were present
within the limits of customary sodium intake, an answer might
be forthcoming to the vexing problem of seemingly random
discrepancies in daily urinary c&cium measurements. In addi-
tion, careful standardization of dietary sodium would become
necessary before assigning stone-forming subjects to various
diagnostic categories. Finally, long-term patient management
might be improved by stricter adherence to a low sodium as
well as to a calcium-restricted diet.
Method
Fourteen male and four female stone-forming subjects were
studied. Each showed hypercalciuria according to the criteria of
Hodgkinson and Pyrah [91 with mean value in excess of 300 mg/
day in the male or 250 mg/day in the female in a number of
preliminary random collections as an out-patient on unrestrict-
ed diet. Seventeen patients were classified as 'idiopathic hyper-
calciuria,' and one male had Klinefelter syndrome with mild
osteoporosis.
The protocol was carried out on an ambulatory basis in each
subject as follows:
Dietary calcium was restricted moderately in the range 500 to
700 mg/day by elimination of cheese intake, and restriction of
milk to one-half pint. Dietary sodium was adjusted to 80 mEq
daily by elimination of processed meats or fish, sauces, canned
vegetables, and salt at table. Bread intake was restricted to 180
g daily. In the case of two subjects, estimated dietary sodium
was rather lower than 80 mEq: it was 40 mEq in one subject and
54 mEq in the other. A 24-hr urine sample collection was
carried out on day 7 of this regime, and on completion the
following morning, a fasting 2-hr 'spot' urine sample was
collected from 7 to 9 A.M. with a serum sample taken during that
interval. Subsequently, the same diet was continued for a
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Table 1. The effect of alteration in dietary sodium on serum and urinary constituents in 18 subjects with hypercalciuria and renal stone disease
Low Na diet High Na diet
PMean SD Mean SD
Serum
Total Ca, mg/di 9.80 0.34 9.68 0.36 <0.05
Ionized Ca, mg/di 4.90 0.19 4.82 0.18 <0.2
Phosphate, mg/di 3.12 0.48 2.97 0.44 <0.01
Sodium, mEq/iiter 141 2.2 141 2.2 NS
iPTH, ng/mi 0.09 0.085 0.108 0.085 NS
24-Hr urine
Volume, mI/day 1829 791 1846 652 NS
Ca, mg/day 278 76 384 91 <0.001
Na, mEq/day 73 33 177 49 <0.001
Ccr, mi/mm 110 19 118 23 <0.02
2-Hr 'spot' urine
Na, mEq/min 0.043 0.032 0.133 0.068 <0.001
Ca, mg/mm 0.138 0.045 0.178 0.061 <0.01
Ca, mg/di GF 0.136 0.044 0.175 0.051 <0.001
Ca/Cr, mg/mm 0.132 0.043 0.175 0.057 <0.001
Ca filtered ionized, % 2.78 0.88 3.61 1.01 <0.001
Ccr, mi/mm 103 17 103 18 NS
TRP, % 89.6 3.8 88.6 3.2 <0.2
TMPO4/GF 3.11 0.59 2.84 0.47 <0.02
cAMP, mm/di GF 4.23 1.64 5.79 3.56 NS
further 7 days with the addition of oral sodium chloride 120
mEq/day, calculated to bring total sodium intake to 200 mEq
daily. A 24-hr urine sample collection was again made on day 14
together with a fasting 'spot' urine and serum samples on the
following morning. Throughout the study each subject received
careful dietary instructions from the dietitian on the metabolic
floor and in the day-care ward. Urine samples were collected in
chemically clean plastic bottles for 24-hr samples and acidified
before analysis (10 ml concentration HCI/liter urine).
Statistical calculations were performed using analysis of
variance and Student's t test for paired observations. The 95%
limit of probability was accepted as significant.
Measurements of serum sodium, serum total, and ionized
calcium, inorganic phosphate, creatinine and in some cases
immuno-reactive parathyroid hormone (iPTH) were also re-
corded on the final day of each dietary period [10, 11]. These
measurements were combined with the morning 'spot' urine
measurements to express urinary calcium per deciliter of
glomerular filtrate and 'percent filtered ionized calcium' in
addition to simple urinary calcium/creatinine ratio. The expres-
sion 'percent filtered ionized calcium' is an approximation
which ignores the contribution of the small component of
complexed nonprotein-bound serum calcium to urinary calci-
um. cAMP excretion was also measured [12, 13] on the 'spot'
urine samples from ten patients (Table 1), using Kit TRK 432
from the Radiochemical Centre, Amersham, England. Normal
values for urinary cAMP in our laboratory are 3.6 1.4 nmoles/
dl GF (N = 9). Total serum and urinary calcium and sodium
were measured by atomic absorption spectroscopy using an IL
instrument. Values for total calcium derived from 41 normal
subjects were 9.0 to 10.6 mg/dl (±2 SD) or 8.6 to 11.0 mg/dl (±3
SD). Serum ionized calcium measurements were performed with
the Orion flow through electrode Model 92-10. Normal values
from 24 healthy subjects were 4.1 to 5.3 mg% (±2 SD) and 3.8 to
5.6 mg% (±3 SD). Serum iPTH values were measured by
radioimmunoassay using a C terminal specific antiserum Chick-
en 9, developed by Dr. E. Slatopolsky (Barnes Hospital, St.
Louis, Missouri) and kindly donated by him. Using this antise-
rum, circulating PTH was detectable in 97% of normal subjects
(range, 0 to 0.33 ng/ml), and values were elevated in 49 of 51
subjects with proven primary hyperparathyroidism [11].
Results
Daily urinary sodium excretion at the end of each of the 2
weeks of study was reasonably consistent with the prescribed
intake of that week at 73 33 and 177 49 mEq (Fig. I and
Table 1). Corresponding values for fasting 'spot' urine sodium
were 0.043 and 0.133 pEq/min.
Daily urinary calcium had decreased to 278 76 following
low sodium intake, rising to 384 91 mg/day on high sodium
diet (P < 0.001). Significant changes in serum ionized calcium
or sodium were not evident, and serum total calcium showed a
small decrease on high sodium intake. Nine of 18 subjects
studied had reduced urinary calcium to less than 300 mg/day
and had therefore fallen into the normocalciuric range of
Hodgkinson and Pyrah [9], following seven days of low sodium
diet. An additional four were less than 320 mg/day (Fig. 1). Of
the five subjects with urine calcium persisting above 320 mg,
two showed coincident urinary sodium unexpectedly high in
relation to their recommended dietary sodium allowance, at 126
and 154 mEq compared to 73 33 mEq/24 hr for the group as a
whole. Poor dietary compliance, therefore, may be suspected in
these subjects. One subject only showed a slight decrease in
urine calcium following high sodium diet, but a marked de-
crease in C. from 91 to 77 mI/mm probably reflects an
incomplete urine collection at that time.
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Seventeen subjects satisfactorily completed the fasting morn-
ing 2-hr 'spot' urine sample collections at the end of each of the
2 weeks of study. One subject had 'spot' urine collection on a
low sodium diet only. On high sodium intake, urine calcium was
expressed as mg/dl. GF was raised in 15 of 17 patients (Fig. 2)
when compared to values for nine control subjects studied in
this department [1]. The three subjects with normal urine
calcium (mg/dl GF) at this stage also had 24-hr urine calcium
values of less than 300 mg/24 hr. The data of Pak et al [8]
indicate an upper limit of 0.11 mg/dl GF for normal 'spot' urine
calcium on a 400 mg Ca intake, and by chance, this limit agrees
closely with the 0.121 mg/dI GF which was the +1 SD of our
recently published normal subjects [11. Using this limit as an
arbitrary dividing line between 'renal' and 'absorptive' hyper-
calciuria (Fig. 2), 15 of 17 patients on the 200 mEq diet would be
classified as having 'renal' hypercalciuria. However, six had
fallen into the 'absorptive' grouping following seven days of 80
mEq of sodium.
A similar pattern was seen when using the simpler urinary
calcium/creatinine ratio as well as urinary calcium 'percent
filtered ionized calcium'. In all methods of expression a highly
significant decrease in urinary calcium accompanied decreased
urinary sodium on the low sodium intake.
Serum iPTH values measured in ten subjects were normal in
six, and in the undetectable range in four, without significant
change between the first and second weeks of study. Urinary
cAMP values (Table 1) were rather higher than our normal
controls (3.6 1.4 nmoles/dl GF) and also exceeded the normal
range of 3.74 1.3 nmoles/dl quoted by Pak et al [8]. They did
not change significantly with changing sodium intake.
Serum inorganic phosphate fell slightly but significantly (P <
0.01) on the higher sodium regime, and this was accompanied
by a lowering of the tubular phosphate reabsorptive threshold
(TMPO4/GF) (P < 0.02) [91.
Discussion
The results show that 24-hr urinary excretion of calcium is
affected significantly by change in dietary sodium intake in the
range, 80 to 200 mEq. Our data support those of Kleeman et al
[2] with the additional information that important changes in
urinary calcium can result from relatively minor dietary sodium
adjustments. The pattern in Figure 1 indicates that most of
those subjects previously shown to be hypercalciuric on multi-
ple random collections were confirmed as such following a
week of 200 mEq sodium intake but were converted to apparent
normocalciuria during the 80 mEq sodium regime. Such mis-
leadingly low values for urinary calcium may also result when
concomitant urinary sodium is lowered by other circumstances
such as physical exertion, severe sweating or the postoperative
state. The latter seems particularly important since diagnostic
studies in the busy hospital setting may often be carried out in
the immediate aftermath of stone removal, Renal stone sub-
jects, therefore, must be studied during a steady state with
sodium intake of not less than 200 mEq before hypercalciuria
can be confirmed validly or excluded.
Our findings were surprising in view of the recent conclusions
of Lemann, Adams, and Gray [31 that urinary calcium may be
expected to alter by a mere 24 mg/100 mEq increment in urinary
sodium. McCarron et al [14] have also recorded an increase of
only 65 mg in urinary calcium as urinary sodium was raised
from 18 to 249 mEq, though this figure may be biased by a very
short intervening time of 3 days. Both studies were carried out
in normal subjects. Our data in Table I suggest a mean figure of
97 mg increase in daily urinary calcium when urinary sodium
increases by 100 mEq. It appears that the hypercalciuric subject
may be essentially different from normal in respect to the slope
of a regression of urinary calcium on urinary sodium, analogous
to the differing slopes of urinary calcium versus dietary calcium
as reviewed by Lemann, Adams, and Gray [31. Both the
absolute levels and the degree of change in dietary sodium in
the current study appear well within the range expected during
normal day-to-day dietary alterations. Such variation, there-
fore, may be an important factor in the known and troublesome
swings in urinary calcium commonly encountered during ambu-
latory diagnostic studies.
Pak et al [81 have been careful to specify a recommended
fixed dietary sodium intake of 100 mEq during the 'restricted'
phase of their recent studies. However, we would note that the
recorded urinary sodium excretion was frequently in excess of
this and also quite variable between groups. Perhaps this was
fortunate, since 100 mEq if adhered to is dangerously close to
our 80-mEq regime, which successfully disguised underlying
hypercalciuria in many of our subjects. It is of interest to
examine closely the data of Pak et al [81 in the light of our
present conclusions. In particular, the essential difference be-
tween their 'absorptive type 1' and 'absorptive type 2' group-
ings is that daily urinary calcium was above 200 mg in type 1
and below 200 mg in type 2 when on a 400 mg Ca and 100 mEq
Na diet. However, dietary compliance on their ambulatory
protocol was clearly variable, to the extent that urinary sodium
was 133 63 in their type 1 group and 92 45 in type 2. On the
basis of our current data, obtained on a very slightly different
diet, we would suggest that the lower urinary calcium in their
'type 2' may be explained simply on the basis of the lower
urinary sodium in that group. Also, we note further that their
'renal' grouping, that is, subjects with the highest fasting
urinary calcium, showed the highest urinary sodium at 141
66. Differences in urinary sodium therefore may be at the root
of these rather arbitrary diagnostic classifications.
Pak et al [8] suggested that the hypothetical 'renal' and
'absorptive' categorization of hypercalciuria is supported by
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Fig. 1. Twenty-four hour urinary calcium in relation to urinwy sodium
on low sodium intake (open symbols) and high sodium intake (closed
symbols) in idiopathic hypercalciuria. The dashed line represents the
upper limit of normal for males as described by Hogkinson and Pyrah
[9].
Fig. 2. Two-hour morning urine calcium,
expressed per deciliter glomerular filtrate, as
calcium to creatinine ratio, and as percent
filtered ionized calcium following low and high
sodium intake. The dashed line represents
upper limit of normal (one SD) in control
subjects [1].
independent evidence in that the 'renal' group shows elevation
of either serum iPTH or urinary cAMP whereas the 'absorptive'
cases do not. In our experience, however, subjects with an
apparently 'renal' pattern of morning hypercalciuria show se-
rum iPTH within normal limits provided that marginal or
'normocalcemic' hyperparathyroidism has been excluded [1,
10, 15]. Ten subjects of the present series confirm this experi-
ence. Urinary cAMP was elevated slightly but did not differ
between 'absorptive' or 'renal' subjects in this study. It is
evident that some subjects changed from one apparent category
of hypercalciuria to the other during sodium manipulation
without any significant alteration in either serum iPTH or
urinary cAMP. The results confirm our earlier view [15] that
there is no real benefit in persisting with the arbitrary 'renal'
versus 'absorptive' subdivisions of hypercalciuria.
If restriction of dietary sodium to 80 mEq daily for 1 week
results in reduction of hypercalciuria to normal levels, it may be
asked fairly if maintenance of such a diet would continue to
control urinary calcium for longer periods. If so, a potentially
valuable mode of therapy may result, analogous to the success-
ful control achieved by Porter et al [161 in the particular
circumstances of hypoparathyroidism where a low salt diet was
combined with chlorthalidone therapy to reduce urinary calci-
um and maintain serum calcium levels. An added advantage
would be the possibility of maintaining normocalciuria without
the need for additional thiazide therapy, with its attendant
hazards of hypercalciuria, glucose intolerance, and increased
renal phosphate loss. Sodium restriction may provide a more
complete mode of treatment in the syndrome by reversing the
tubular leak of both calcium and phosphate. Patient compliance
is obviously a crucial factor here, but an immediate and
convenient check is provided by the simultaneous estimate of
urinary sodium as well as calcium in each collection as shown in
this study.
Since the effect of dietary sodium change persists to the
following morning after at least 8 to 10 hr of fasting, it appears
independent of recent intestinal sodium absorption. 'Spot' urine
sodium was also higher at this time suggesting that extracellular
fluid volume or 'third factor' signals may be important regula-
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tory factors governing both sodium and calcium excretion in the
fasting state. In support of this possibility is the slight increase
in creatinine clearance found in the 24-hr samples, though not
seen in the short 'spot' collections. A number of earlier
observations by other investigators confirm the concurrence of
urinary sodium and calcium excretion under a variety of
experimental conditions [4—7]. The 'third factor' signal govern-
ing the observed alterations in tubular function may be an
increased circulating level of natriuretic factor, such as an
inhibitor of renal sodium-potassium dependent ATPase [171.
Tubular phosphate reabsorption and serum phosphate have
been shown previously to fall following extracellular volume
expansion in normal man [181. The concurrence of falling
tubular reabsorption of both calcium and phosphate together
with mild hypophosphatemia is reminiscent of the two main
features of idiopathic hypercalciuria syndrome as described by
Henneman et al [19]. The present data indicate that both are at
least partly dependent on sodium intake in hypercalciuria.
The intriguing possibility therefore arises that the idiopathic
hypercalciuria syndrome may be provoked by high sodium
intake. Habitual dietary sodium intake has not been formally
assessed in these subjects prior to study, but we have been
struck by the number who have admitted to being unusually
fond of salt and for whom the advised 80-mEq intake appeared
at first to be an unattainable target. For the future we would
suggest that a careful dietary assessment of sodium intake be
made prior to any dietary manipulation with its consequent
increase in patient awareness. In addition, urinary sodium as
well as calcium should be measured in random ambulatory
collections at home, because urinary sodium accurately reflects
intake in the steady state. By both means it should be possible
to assess in a larger number of subjects whether or not habitual
high sodium intake may be a significant factor in the generation
of the hypercalciuria syndrome.
Acknowledgments
The authors thank Sister Doyle of the Metabolic Ward and Sister
Donnelly of the Day Care Ward, St. Vincent's Hospital, and Miss
McMahon for typing the manuscript.
Dietary sodium in the hypercalciuria syndrome 295
0.30
0.20
0.10
o Low Na diet 0 Low Na diet
S High Na diet • High Na diet
p<0.001
O Low Na diet
• High Na diet
296 Muldownev et al
Reprint requests to Prqfrssor F. P. Muldowney, Depart,nent of
Metabolism, Sr. Vincent's Hospital, Elm Park, Dublin 4, Ireland
References
1. MULDOWNEY FP: Diagnostic approach to hypercalciuria. Kidney
mt 16:637—648, 1979
2. KLEEMAN CR, BOHANNAN J, BERNSIEIN D, LING S MAXWELL
MH: Effect of variation in sodium intake on calcium excretion in
normal humans. Proc Soc Ecp Biol Med 115:29—32, 1964
3. LEMANN J, ADAMS ND, GRAY RW: Urinary calcium excretion in
human beings. N EnglJ Med 301:535—541, 1979
4. CHEN PS, NEUMAN WF: Renal excretion of calcium by the dog.
Am J Physiol 180:623—631, 1955
5. WALSER M: Calcium clearance as a function of sodium cleErance in
the dog. Am J Physiol 200:1099—1104, 1961
6. EPSTEIN Fl-i: Calcium and the kidney. Am J Mccl 45:700—714, 1968
7. KING JS JR, JACKSON R, ASHE B: Relationship of sodium intake to
urinary calcium excretion. Invest ljrol 1:555—560, 1964
8. PAK CYC, BRITTON F, PETERSON R, WARD D, NORTI-ICUTT C,
BRESLAU NA, MCGUIRE J, SAKHAEE K, BUSH S, NICAR M,
NORMAN DA, PETERS P: Ambulatory evaluation of nephrolithiasis.
Am J Med 69: 19—30,1980
9. HODGKINSON A, PYRAH LH: The urinary excretion of calcium and
inorganic phosphate in 344 patients with calcium stone of renal
origin. Br J Surg 46:10—18, 1958
10. MULDOWNEY FP, FREANEY R, MCMULLIN JP, TOWERS RP,
SPILLANE A, O'CONNOR P, O'DONOGIIUE P. MOLONEY M: Serum
ionised calcium and parathyroid hormone in renal stone disease. Q
J Med 45:75—86, 1976
11. FREANEY R, RYAN EA, MULDOWNEY FP: Differentiation of hyper-
calcaemia due to malignancy from primary hyperparathyroidism:
The value of parathyroid hormone and plasma bicarbonate mea-
surements. Ir J Med Sci 150:6—12, 1981
12. GILMAN AG: A protein binding assay for adenosine 35' cyclic
monophosphate. Proc Nail Acad Sci USA 67:305—3 12, 1970
13. BROWN BL, ARBANO JDM, EKINS RP, SCI-IEWZI AM, TAMPION W:
A simple and sensitive saturation assay method for the measure-
ment of adenosine 3'S' cyclic monophosphate. Biochem J 12 1:561—
562, 1971
14. MCCARRON DA, RANKIN LI, BENNETT WM, KRUTZIL S,
MCCLUNG MR, LUFT FC: Urinary calcium excretion at extremes
of sodium intake in normal man. Am J Nephrol 1:84—90, 1981
15. MULDOWNEY FP, FREANEY R, RYAN JG: The pathogenesis of
idiopathic hypercalciuria: Evidence of renal tubular calcium leak. Q
J Med 49:87—94, 1980
16. PORTER RH, Cox BG, HEANEY D, HOSTETTER TH, STINEBAUGH
RJ, SUKI W: Treatment of hypoparathyroid patients with chlortha-
lidone. N Engi J Med 298:577—581, 1978
17. DE WARDENER HE, MCGREGOR GA, CLARKSON EM, AL-
AGHBAND-ZADEH J, BITENSKY L, CIIAYEN J: Effect of sodium
intake on ability of human plasma to inhibit renal Na-K-adenosine-
Triphosphatase in vitro. Lancer 1:41 1—412, 1981
18. STEELE TH: Increased urinary phosphate excretion following vol-
ume expansion in normal man. Metabolism 19:129—139, 1970
19. HENNEMAN PH, BENEDICT PH, FORBES AP, DUDLEY HP: Idio-
pathic hypercalciuria. N Engl J Med 259:802—807, 1958
